| Financial Year |
March 31 2023 |
| Monetary Funds |
1,415,901,279.59 |
| Held-for-trading Financial Assets |
39,638,465.87 |
| Notes Receivable |
-- |
| Accounts Receivable |
410,349,009.57 |
| Advances to Suppliers |
118,610,394.78 |
| Other Receivables |
80,531,250.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,111,343,054.89 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
42,118,328.77 |
| Other Current Assets |
1,187,299.24 |
| Total Current Assets |
4,219,679,083.51 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
3,556,697.09 |
| Long-term Equity Investment |
349,420,072.22 |
| Investment Properties |
-- |
| Fixed Assetes |
4,984,983,137.46 |
| Under-construction Projects |
991,303,421.70 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,716,870,337.69 |
| R&D expenses |
-- |
| Goodwill |
41,968,889.08 |
| Long-Term Deferred and Prepaid Expenses |
1,113,012.31 |
| Deferred Income Tax Assets |
70,050,643.30 |
| Other Non-Current Assets |
146,636,531.40 |
| Sub-Total of Non-Current Assets |
13,537,722,725.71 |
| Total Assets |
17,757,401,809.22 |
| Short-Term Loans |
529,393,761.37 |
| Trading Financial liabilities |
952,879,880.00 |
| Notes Payable |
90,000,000.00 |
| Accounts Payable |
650,344,675.59 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
83,070,927.96 |
| Taxes Payable |
266,835,805.39 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
558,493,243.18 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
362,324,512.66 |
| Other Current Liabilities |
396,342.57 |
| Sub-Total of Current Liabilities |
3,563,925,385.77 |
| Long-term Loans |
1,421,373,123.74 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
79,271,711.94 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,959,856,316.79 |
| Deferred Income Tax Liabilities |
2,429,259,108.85 |
| Other Non-Current Liabilities |
592,395,823.44 |
| Sub-Total of Non-Current Liabilities |
6,706,665,274.62 |
| Total Liabilities |
10,270,590,660.39 |
| Paid-In Capital(Or Share Stock) |
1,663,911,378.00 |
| Capital Surplus |
626,613,563.85 |
| Surplus Reserve |
132,124,232.09 |
| LESS:Treasury Stock |
300,787,044.21 |
| Undistributed Profits |
3,154,421,391.58 |
| Minority Stockholder's Interest |
2,284,817,525.41 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,201,993,623.42 |
| Owner's Equity（Stockholder's Equity） |
7,486,811,148.83 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
17,757,401,809.22 |
